RB1 and small cell lung carcinoma: Due to the limited NEPC models, we took advantage of the fact that small-cell neuroendocrine carcinomas (SCNC), including small-cell lung cancer (SCLC), and NEPC share similar genomic characteristics, such as RB1 deletion and TP53, mutation independent of the tissue of origin (14, 16–18).